Paris, France

Carole Jellimann


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Carole Jellimann: Innovator in Pharmaceutical Compounds

Introduction

Carole Jellimann is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of tricyclic compounds. His work is essential for advancing medical treatments and improving patient care.

Latest Patents

Carole Jellimann holds a patent for "Tricyclic compounds, preparation method and pharmaceutical compositions containing same." This invention concerns compounds of formula (I), where A forms a tricyclic system of various specified formulas. The patent outlines that R can represent a hydrogen atom, an alkyl, hydroxy, alkoxy, or oxo group. The invention is particularly useful for preparing medicines, showcasing Jellimann's commitment to enhancing healthcare solutions. He has 1 patent to his name.

Career Highlights

Throughout his career, Carole Jellimann has worked with Les Laboratoires Servier, a prominent pharmaceutical company. His role at the company has allowed him to focus on innovative research and development in the pharmaceutical sector. His contributions have been instrumental in creating effective medicinal compounds.

Collaborations

Carole has collaborated with esteemed colleagues such as Michel Langlois and Monique Mathe-Allainmat. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Carole Jellimann's work in the field of pharmaceutical compounds exemplifies the impact of innovation on healthcare. His patent for tricyclic compounds highlights his dedication to improving medical treatments. Through his career at Les Laboratoires Servier and collaborations with other professionals, Jellimann continues to contribute significantly to the advancement of pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…